ExodusPoint Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,322
| Closed | -$42K | – | 1822 |
|
|
2024
Q4 | $42K | Buy |
+41,322
| New | +$42K | ﹤0.01% | 1306 |
|
|
2023
Q4 | – | Sell |
-1,890,425
| Closed | -$1.13M | – | 1915 |
|
|
2023
Q3 | $1.13M | Sell |
1,890,425
-193,208
| -9% | -$116K | 0.01% | 879 |
|
|
2023
Q2 | $2.71M | Buy |
2,083,633
+774,310
| +59% | +$1.01M | 0.02% | 612 |
|
|
2023
Q1 | $2.3M | Buy |
1,309,323
+1,089,804
| +496% | +$1.92M | 0.02% | 727 |
|
|
2022
Q4 | $689K | Sell |
219,519
-133,211
| -38% | -$418K | 0.01% | 1044 |
|
|
2022
Q3 | $1.73M | Buy |
352,730
+39,288
| +13% | +$192K | 0.02% | 834 |
|
|
2022
Q2 | $1.3M | Buy |
+313,442
| New | +$1.3M | 0.02% | 914 |
|
|
2022
Q1 | – | Sell |
-72,815
| Closed | -$546K | – | 2560 |
|
|
2021
Q4 | $546K | Buy |
72,815
+9,937
| +16% | +$74.5K | 0.01% | 1315 |
|
|
2021
Q3 | $567K | Sell |
62,878
-113
| -0.2% | -$1.02K | 0.01% | 1259 |
|
|
2021
Q2 | $754K | Buy |
+62,991
| New | +$754K | 0.01% | 1077 |
|
|
2021
Q1 | – | Sell |
-20,611
| Closed | -$322K | – | 2482 |
|
|
2020
Q4 | $322K | Sell |
20,611
-30,049
| -59% | -$469K | ﹤0.01% | 1437 |
|
|
2020
Q3 | $479K | Buy |
+50,660
| New | +$479K | 0.01% | 988 |
|
|
2020
Q1 | – | Sell |
-10,039
| Closed | -$84K | – | 1525 |
|
|
2019
Q4 | $84K | Sell |
10,039
-6,431
| -39% | -$53.8K | ﹤0.01% | 1384 |
|
|
2019
Q3 | $149K | Buy |
16,470
+5,470
| +50% | +$49.5K | 0.01% | 1156 |
|
|
2019
Q2 | $118K | Buy |
+11,000
| New | +$118K | ﹤0.01% | 982 |
|